Top Markets
Coin of the day
Genenta Science S.p.A. Genenta Science S.p.A.

Genenta Science S.p.A.

GNTA
Rankning i aktier #28068
Genenta Science S.p.A. is an Italian clinical-stage biotechnology firm focused... Genenta Science S.p.A. is an Italian clinical-stage biotechnology firm focused on pioneering hematopoietic stem cell gene therapies to combat solid tumors. Its primary therapeutic candidate, Temferon, is currently undergoing Phase 1/2a clinical evaluation. This innovative therapy is being developed to treat glioblastoma multiforme, specifically targeting patients whose tumors exhibit an unmethylated MGMT gene promoter. Beyond this, Genenta Science is exploring Temferon's potential application in various other solid tumor types, including locally advanced hepatocellular carcinoma and intra-hepatic cholangiocarcinoma. Established in 2014, the company maintains its headquarters in Milan, Italy.
Aktiekurs
$1.51
Senast synkroniserad: 2026-07-31
Marknadsvärde
$28.82M
Förändring (1 dag)
-0.33%
Förändring (1 år)
-57.49%
Land
IT
Handel Genenta Science S.p.A. (GNTA)

Kategori

Aktiekurshistorik för Genenta Science S.p.A. (GNTA)
Högsta slutkurs: $1.55 den 2026-07-01

Lägsta slutkurs: $11.33 den 2021-12-01
Aktiekurshistorik för Genenta Science S.p.A. från 2021 till 2026
Årlig aktiekursutveckling
År Prestanda
2026 (TTM) 7.52%
2025 -68.48%
2024 -0.35%
2023 -6.83%
2022 -51.72%
2021 0.00%
Aktiekurs för liknande företag eller konkurrenter
Företag Aktiekurs Förändring 1år% Land
$552.07 39.99%
US
$168.77 527.63%
US
$1.03K 56.22%
NL
$120.74 -14.98%
AU
$753.28 5.84%
CH